Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial

Authors: Agnès Hartemann, G. Bensimon, Christine Payan, Sophie Jacqueminet, Olivier Bourron, Nathalie Nicolas, Michèle Fonfrède, Michèlle Rosenzwajg, Claude C.A. Bernard, David Klatzmann - The Lancet 2013 cited by 422